Paid Clinical Trials Thousand Oaks
Discover 2,976 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Elacestrant, CombinationOpen-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer
Sponsor:
Stemline Therapeutics, Inc.
Location:
Code:
NCT05563220
Conditions
Breast Cancer
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Elacestrant
Alpelisib
Everolimus
Ribociclib
Palbociclib
ABBV-453A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Sponsor:
AbbVie
Location:
Code:
NCT06291220
Conditions
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Obinutuzumab
ABBV-453
EVO756A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria
Sponsor:
Evommune, Inc.
Location:
Code:
NCT06603220
Conditions
Chronic Inducible Urticaria
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Oral EVO756
VedolizumabA Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Sponsor:
Takeda
Location:
Code:
NCT04779320
Conditions
Crohn's Disease (CD)
Eligibility Criteria
Sex: All
Age: 2 - 17
Healthy Volunteers: Not accepted
Interventions
Vedolizumab IV
Observational StudyThe PEERLESS II Study
Sponsor:
Inari Medical
Location:
Code:
NCT06055920
Conditions
Pulmonary Embolism
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FlowTriever System
Anticoagulation Agents
Single vs. MultipleComparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Sponsor:
Weill Medical College of Cornell University
Location:
Code:
NCT04124120
Conditions
Heart Diseases
Coronary Artery Disease
Coronary Artery Bypass Grafting
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Single arterial graft
Multiple arterial grafting
RMC-6236Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Sponsor:
Revolution Medicines, Inc.
Location:
Code:
NCT06625320
Conditions
Pancreatic Cancer
PDAC
PDAC - Pancreatic Ductal Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RMC-6236
Gemcitabine
nab-paclitaxel
Irinotecan
Liposomal irinotecan
MET233 & MET097A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes
Sponsor:
Metsera
Location:
Code:
NCT06924320
Conditions
Obesity and Obesity-related Medical Conditions
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
MET233 and MET097
Placebo
MET233
N-acetylcysteineOral N-acetylcysteine for Retinitis Pigmentosa
Sponsor:
Johns Hopkins University
Location:
Code:
NCT05537220
Conditions
Retinitis Pigmentosa
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
N-acetylcysteine
Placebo
BemarituzumabA Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
Sponsor:
Amgen
Location:
Code:
NCT05325866
Conditions
Solid Tumors
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Bemarituzumab